Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
BMJ Case Reports
|
June 2, 2026
Management of inherited fibrinogen disorder during chemotherapy and allogeneic stem cell transplant
Yiseiry Perez-Melendez, Tharakeswari Selvakumar, Charles Greenberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 24, 2021
Evaluating Race and Time to Transplantation in Multiple Myeloma: The Mount Sinai Hospital Experience
Darren Pan, Alexander Coltoff, Umut Ozbek, et al.
Carcinogenesis
|
February 5, 2019
Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia
Geetanjali R Kamath, Douglas Tremblay, Alexander Coltoff, et al.
Leukemia Research
|
December 30, 2018
Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients
Geetanjali R Kamath, Douglas Tremblay, Alexander Coltoff, et al.
Open Forum Infectious Diseases
|
May 19, 2020
Practicing Antimicrobial Stewardship: De-Escalating Antibiotics in Patients With Acute Myeloid Leukemia and Neutropenic Fever
Risa Fuller, Erin Moshier, Samantha E Jacobs, et al.
Blood Advances
|
August 12, 2025
Efficacy of Eculizumab Discontinuation in Atypical Hemolytic Uremic Syndrome: A Systematic Review and Meta-analysis
Amy Hockman, Sydney Anuskiewicz, Emily Brennan, et al.
Molecular and Cellular Biology
|
March 4, 2015
Brk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4
Priyank Patel, Benedikt Asbach, Elina Shteyn, et al.
Leukemia Research
|
January 23, 2026
Clinical utility of interim bone marrow biopsies in FLT3 mutant acute myeloid leukemia
Vincent Lok, Katie Moffitt, Dahniel Sastow, et al.
Leukemia & Lymphoma
|
November 13, 2019
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis
Douglas Tremblay, Amber King, Lihua Li, et al.
Scientific Reports
|
November 14, 2019
Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Manali Sapre, Douglas Tremblay, Eric Wilck, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
BMJ Case Reports
|
June 2, 2026
Management of inherited fibrinogen disorder during chemotherapy and allogeneic stem cell transplant
Yiseiry Perez-Melendez, Tharakeswari Selvakumar, Charles Greenberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 24, 2021
Evaluating Race and Time to Transplantation in Multiple Myeloma: The Mount Sinai Hospital Experience
Darren Pan, Alexander Coltoff, Umut Ozbek, et al.
Carcinogenesis
|
February 5, 2019
Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia
Geetanjali R Kamath, Douglas Tremblay, Alexander Coltoff, et al.
Leukemia Research
|
December 30, 2018
Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients
Geetanjali R Kamath, Douglas Tremblay, Alexander Coltoff, et al.
Open Forum Infectious Diseases
|
May 19, 2020
Practicing Antimicrobial Stewardship: De-Escalating Antibiotics in Patients With Acute Myeloid Leukemia and Neutropenic Fever
Risa Fuller, Erin Moshier, Samantha E Jacobs, et al.
Blood Advances
|
August 12, 2025
Efficacy of Eculizumab Discontinuation in Atypical Hemolytic Uremic Syndrome: A Systematic Review and Meta-analysis
Amy Hockman, Sydney Anuskiewicz, Emily Brennan, et al.
Molecular and Cellular Biology
|
March 4, 2015
Brk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4
Priyank Patel, Benedikt Asbach, Elina Shteyn, et al.
Leukemia Research
|
January 23, 2026
Clinical utility of interim bone marrow biopsies in FLT3 mutant acute myeloid leukemia
Vincent Lok, Katie Moffitt, Dahniel Sastow, et al.
Leukemia & Lymphoma
|
November 13, 2019
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis
Douglas Tremblay, Amber King, Lihua Li, et al.
Scientific Reports
|
November 14, 2019
Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Manali Sapre, Douglas Tremblay, Eric Wilck, et al.
Page
of 3